A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
Recruiting in Palo Alto (17 mi)
MB
Overseen byMarc Bloomenstein, M.D.
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: Innovative Medical
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?
To evaluate the safety and efficacy of BLINK™ tears compared with NO topical artificial tear use in improving subject's visual performance and reduce ocular symptoms of discomfort in subjects who have undergone cataract surgery implanted with a Tecnis™ diffractive multifocal intraocular lens (IOL).
Research Team
MB
Marc Bloomenstein, M.D.
Principal Investigator
Schwartz Laser Eye Center
Eligibility Criteria
Inclusion Criteria
Male or female subjects, 21 years of age or older
Written, informed consent and HIPPA Authorization
Has 20/40 or better best corrected visual acuity in the surgical eye at the Day 1 post-op visit (Visit 3)
See 3 more
Treatment Details
Interventions
- Blink® Tears Lubricant Eye Drops (Artificial Tears)
- No topical artificial tear (Behavioural Intervention)
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: BLINK™ tearsExperimental Treatment1 Intervention
Group II: No topical artificial tearActive Control1 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Innovative Medical
Lead Sponsor
Trials
52
Recruited
2,600+